Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy
Upperton advances sterile manufacturing facility following MHRA submission.
Influence of L-Leucine Content on the Internal and External Morphology of Spray-Dried Particles
Upperton advances sterile manufacturing facility following MHRA submission.
Sterile at Speed: Phase I Development in a Post Annex 1 Environment
Securing sterile drug product capacity for early-phase development has never been more challenging. The revised EU GMP Annex 1 guidelines have raised expectations across contamination control, environmental monitoring, and aseptic process validation at precisely the moment global sterile capacity is under its greatest strain. For early-stage biotech and emerging pharma, the impact is immediate. Timelines […]
Liquid Injectables: Stability Issues and How to Avoid Them
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
How are Parenteral Manufacturing Solutions Evolving to Meet the Demands for More Specialised and Sensitive Drug Formulations?
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Upperton Advances Sterile Manufacturing Facility with MHRA Submission
Upperton advances sterile manufacturing facility following MHRA submission.
What Biotech Startups Need to Know About Sterile Fill-Finish Services
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
On-Demand Fireside Chat – Spray Dried Biologics for Injectable Dosage Forms
Webinar – Formulation & Delivery of Spray Dried Biologics for Injectable Dosage Forms
The Bright Side of Biologic Stability: A Thermofluor Screen for Rational Buffer Optimisation
Learn about the challenges of stabilising injectable biologics.